INGN PB Ratio
1.01×TTM
Retrieved:
INGN FY P/B Ratio
32.52×-2.80×
2011-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
INGN pb ratio history
Price-to-book ratio. The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.
| Period ending | PB Ratio |
|---|---|
| 0.95× | |
| 1.2476× | |
| 0.6212× | |
| 1.5145× | |
| 2.0654× | |
| 2.809× | |
| 4.3266× | |
| 9.0058× | |
| 10.8484× | |
| 7.4025× | |
| 5.803× | |
| 4.2966× | |
| 4.8569× | |
| 7.6964× | |
| 29.1061× |
Compare pb ratio
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) pb ratio
- Bridgebio Pharma Inc (BBIO) pb ratio
- Brightspring Health Services Inc (BTSG) pb ratio
- Madrigal Pharmaceuticals Inc (MDGL) pb ratio
- Ensign Group Inc (ENSG) pb ratio
- Glaukos Corp (GKOS) pb ratio
- Vaxcyte Inc (PCVX) pb ratio
- Krystal Biotech Inc (KRYS) pb ratio
Compare all covered stocks by pb ratio →
All INGN financial metrics · INGN stock overview · How to interpret financial metrics
